Results 211 to 220 of about 7,117 (221)
Some of the next articles are maybe not open access.

Novel BTK inhibitor acalabrutinib (ACP-196) tightly binds to site I of the human serum albumin as observed by spectroscopic and computational studies

International Journal of Biological Macromolecules, 2019
Ali Saber Abdelhameed   +2 more
exaly  

Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib

Thrombosis and Haemostasis, 2019
Isabell Pekrul, , Wolfgang Siess
exaly  

Acalabrutinib/enoxaparin-sodium

Reactions Weekly, 2023
openaire   +1 more source

Acalabrutinib/Ibrutinib

Reactions Weekly
  +4 more sources

Acalabrutinib (Calquence®)

Oncology Times, 2018
openaire   +1 more source

Acalabrutinib/zanubrutinib

Reactions Weekly
openaire   +1 more source

Acalabrutinib/prednisone

Reactions Weekly
openaire   +1 more source

Acalabrutinib/pentoxifylline

Reactions Weekly
openaire   +1 more source

Acalabrutinib/venetoclax

Reactions Weekly
openaire   +1 more source

Acalabrutinib/obinutuzumab

Reactions Weekly
openaire   +1 more source
ibrutinib
diseases of the blood and blood-forming organs
chronic lymphocytic leukemia
atrial fibrillation
hypertension
cll
btk
mantle cell lymphoma
bruton tyrosine kinase inhibitor
previous   20  21  22  23  

Home - About - Disclaimer - Privacy